Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Early intervention in COPD

H J Carveth1, R E Kanner

  • 1Department of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City 84132, USA.

Comprehensive Therapy
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bronchodilator response in the lung health study over 11 yrs.

The European respiratory journal·2005
Same author

Granulomatous pneumonitis following bone marrow transplantation.

Bone marrow transplantation·2001
Same author

Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

American journal of respiratory and critical care medicine·2001
Same author

Acute exposure to environmental tobacco smoke and heart rate variability.

Environmental health perspectives·2001
Same author

Heart rate variability associated with particulate air pollution.

American heart journal·1999
Same author

Endothelial activation in ARDS.

Chest·1999
Same journal

Heparin-induced thrombocytopenia and thrombosis.

Comprehensive therapy·2011
Same journal

Antiplatelet therapy in cardiovascular disease.

Comprehensive therapy·2011
Same journal

Genetics of cardiovascular disease.

Comprehensive therapy·2011
Same journal

Septic renal vein thrombosis complicated by septic pulmonary embolism.

Comprehensive therapy·2011
Same journal

Gout and hyperuricemia.

Comprehensive therapy·2011
Same journal

Problems with computerized health records.

Comprehensive therapy·2011
See all related articles

Smoking cessation is the most crucial intervention for preventing COPD, significantly slowing lung function decline. While airway hyperresponsiveness is a predictor, quitting smoking yields greater benefits than any tested therapy.

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Clinical Trials

Background:

  • The Dutch Hypothesis (35 years ago) proposed early COPD identification and intervention.
  • Focus has been more on identification than therapy due to smoking addiction and the search for pharmacologic treatments.
  • Airway hyperresponsiveness (AHR) was hypothesized to predict accelerated lung function decline in smokers.

Purpose of the Study:

  • To evaluate the predictive role of AHR in lung function decline.
  • To assess the impact of smoking cessation and bronchodilator use on COPD progression.
  • To investigate AHR prevalence, particularly in women, within early COPD cohorts.

Main Methods:

  • Analysis of data from the Lung Health Study.
  • Assessment of methacholine challenge tests to determine AHR.

Related Experiment Videos

  • Comparison of lung function decline rates between smokers who quit and those who continued, and between bronchodilator users and non-users.

    • Main Results:

    • Heightened AHR strongly predicted adverse longitudinal lung function decline.
    • AHR was more prevalent than expected, especially in women (87% vs. 62% in men).
    • Smoking cessation demonstrated a greater benefit in slowing lung function decline than AHR or bronchodilator use.

    Conclusions:

    • Smoking cessation is the paramount intervention for preventing COPD progression.
    • Bronchodilator use (ipratropium) did not prevent the decline in lung function in the study.
    • Early identification of AHR is important, but addressing smoking is critical for managing COPD risk.